Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Internal Medicine
LV Thrombus
Questions discussed in this category
Is it reasonable to consider the use of DOACs for LV thrombus management instead of coumadin?
3 Answers available
Can DOACs be a reasonable alternative (instead of VKA) for management of LV thrombus post-MI and what is a reasonable follow-up time for surveillance outpatient imaging and subsequent duration of therapy outpatient?
1 Answer available
16576
13827
Papers discussed in this category
JAMA Cardiol,
Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular Thrombi.
Eur Heart J Cardiovasc Pharmacother, 2022 Sep 29
Apixaban vs. warfarin in patients with left ventricular thrombus: a prospective multicentre randomized clinical trial‡.
Eur Heart J Cardiovasc Pharmacother, 2021 Sep 21
The use of novel oral anticoagulants compared to vitamin K antagonists (warfarin) in patients with left ventricular thrombus after acute myocardial infarction.
ESC Heart Fail, 2020 Jun 25
Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus.
Related Topics in Internal Medicine
Lung Cancer
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Cancers
Palliation
Neuro-Oncology
Gastrointestinal Cancers
Genitourinary Cancers